Three researchers of University of Florida, involved in several studies for type 1 (IDDM) diabetes has been awarded by the sixth annual “Excellence in Clinical Research” award at the annual Juvenile Diabetes Research Conference in Washington, D.C.. The award was handed over by Mary Tyler Moore and her husband, Dr, S. Robert Levine.
Their main research work includes development of cure for type 1 diabetes, using umbilical cord blood stem cells as a potential therapy and investigating drug treatments used in tandem to provide immune suppression while boosting the regeneration of insulin-producing cells.
Three researchers are:
1) Mark Atkinson, director of the JDRF (Juvenile Diabetes Research Foundation) Gene Therapy Center for Diabetes and Diabetic Complications at the University of Florida and University of Miami.
2) Dr. Michael Haller, professor of pediatrics in the University of Florida College of Medicine;
3) Dr. Desmond Schatz, medical director of the Diabetes Center of Excellence and associate director of University of Florida’s General Clinical Research Center.
Moore says, that the special qualities what we valued the most in these scientists is the leadership of challenging conventional wisdom and consequent ground breaking work in developing cure and life changing therapies.
Filed under Diabetes, Diabetes Drug, IDDM, Stem cell | Tags: annual Juvenile Diabetes Research Conference, College, Excellence in Clinical Research, Juvenile Diabetes, type 1 (IDDM) diabetes | Comment Below